HOME >> BIOLOGY >> NEWS
UGA study reveals a new way of looking at vaccine development

University of Georgia researchers have given vaccine developers a new tool that could lead to the development of designer vaccines that protect against a wider range of diseases or work against diseases that are currently hard to prevent.

In a study published in the May 23 edition of the journal Proceedings of the National Academy of Sciences, Robert J. Woods and his colleagues demonstrate precisely how antibodies react differently to two common disease-causing bacteria Group B Streptococcus and Streptococcus pneumoniae.

Their 3D modeling technique gives researchers the power to effectively see how the body's antibodies bind to the chains of sugars on the outer coats of bacteria. In cases where antibodies don't bind to the sugars and no immune response is triggered, researchers could chemically alter the sugars so that body recognizes the bacteria as a threat and mounts a defense.

"What you'd really like is to control either the broadness of the immune response so that you can take one vaccine and protect against multiple strains of the bacteria," said Woods, lead author of the study and associate professor of biochemistry at the UGA Complex Carbohydrate Research Center. "Or you could take a strain that's not easy to vaccinate against and induce an immune response using a synthetically modified sugar."

Woods and his colleagues chose to examine Group B Streptococcus and Streptococcus pneumoniae because of their virulence and because they have very similar outer coats. Chemically, strains III and 14 of these two bacteria share a common molecular backbone. The only difference is a missing acidic sugar in the side chain of Streptococcus pneumoniae 14.

The immune system can generate antibodies against both bacteria but despite the similarities in their surface sugars antibodies against the one bacterium do not generally recognize the other and so do not protect against infection by the other.

To understand this lack of
'"/>

Contact: Kim Osborne
kcarlyle@uga.edu
706-542-8083
University of Georgia
22-May-2006


Page: 1 2 3

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2018)... BOSTON and SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 ... ... communications and collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. ... cloud delivering a scalable and secure, quality voice solution that is far superior to ...
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... management solutions to pharmaceutical and biotech companies, today announced that Mark Jara, principal ... most inspiring people in the life sciences industry. Individuals named to PharmaVOICE 100 ...
(Date:8/1/2018)... ... July 31, 2018 , ... ... Awards at Global Conference , Awards honor late founder of Wisdom National Brands® ... National Brands, presented prestigious stevia awards to a renowned German professor and a ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... July 24, 2018 , ... R3 Stem Cell is now ... The treatments are offered by Double Board Certified providers, with outcomes significantly improving patient ... suppressing symptoms, but have done nothing to help repair and regenerate damaged lung tissues. ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/13/2017)... KING OF PRUSSIA, PA (PRWEB) , ... October 13, 2017 , ... ... Group Vice President and Turesol Business Unit Leader, will moderate a discussion on the ... this year’s ISPE Annual Meeting & Expo . The theme of this year’s ...
Breaking Biology Technology:
Cached News: